JP2013531967A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531967A5 JP2013531967A5 JP2012555988A JP2012555988A JP2013531967A5 JP 2013531967 A5 JP2013531967 A5 JP 2013531967A5 JP 2012555988 A JP2012555988 A JP 2012555988A JP 2012555988 A JP2012555988 A JP 2012555988A JP 2013531967 A5 JP2013531967 A5 JP 2013531967A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- foreign gene
- sequence
- polynucleotide sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002157 polynucleotide Substances 0.000 claims 30
- 102000040430 polynucleotide Human genes 0.000 claims 30
- 108091033319 polynucleotide Proteins 0.000 claims 30
- 108090000623 proteins and genes Proteins 0.000 claims 22
- 210000004027 cell Anatomy 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 12
- 230000014509 gene expression Effects 0.000 claims 8
- 239000013604 expression vector Substances 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 210000004748 cultured cell Anatomy 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012555988A JP5859988B2 (ja) | 2010-07-07 | 2011-07-06 | 外来遺伝子発現亢進活性を有するｄｎａエレメント |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010154782 | 2010-07-07 | ||
| JP2010154782 | 2010-07-07 | ||
| JP2012555988A JP5859988B2 (ja) | 2010-07-07 | 2011-07-06 | 外来遺伝子発現亢進活性を有するｄｎａエレメント |
| PCT/JP2011/065916 WO2012005378A2 (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015245827A Division JP6039048B2 (ja) | 2010-07-07 | 2015-12-17 | 外来遺伝子発現亢進活性を有するｄｎａエレメント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531967A JP2013531967A (ja) | 2013-08-15 |
| JP2013531967A5 true JP2013531967A5 (enExample) | 2014-08-14 |
| JP5859988B2 JP5859988B2 (ja) | 2016-02-16 |
Family
ID=44630215
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012555988A Active JP5859988B2 (ja) | 2010-07-07 | 2011-07-06 | 外来遺伝子発現亢進活性を有するｄｎａエレメント |
| JP2015245827A Active JP6039048B2 (ja) | 2010-07-07 | 2015-12-17 | 外来遺伝子発現亢進活性を有するｄｎａエレメント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015245827A Active JP6039048B2 (ja) | 2010-07-07 | 2015-12-17 | 外来遺伝子発現亢進活性を有するｄｎａエレメント |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US9371543B2 (enExample) |
| EP (3) | EP2684961B1 (enExample) |
| JP (2) | JP5859988B2 (enExample) |
| KR (3) | KR101856927B1 (enExample) |
| CN (3) | CN105950621B (enExample) |
| AU (3) | AU2011274864B2 (enExample) |
| BR (1) | BR112012033780A2 (enExample) |
| CA (2) | CA2804381C (enExample) |
| ES (3) | ES2701091T3 (enExample) |
| IL (1) | IL243763A0 (enExample) |
| RU (1) | RU2013104989A (enExample) |
| SG (4) | SG10201505354PA (enExample) |
| TW (2) | TWI507523B (enExample) |
| WO (1) | WO2012005378A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2701091T3 (es) * | 2010-07-07 | 2019-02-20 | Daiichi Sankyo Co Ltd | Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno |
| CN104066839B (zh) | 2011-11-28 | 2018-02-16 | 第一三共株式会社 | 衍生自人基因的启动子 |
| CN109790539A (zh) | 2016-10-03 | 2019-05-21 | 第一三共株式会社 | Hspa5基因的启动子 |
| CN107881174B (zh) * | 2017-11-22 | 2022-06-03 | 张宝会 | 一种翻译水平基因表达调控的方法及应用 |
| US20230192893A1 (en) * | 2020-05-11 | 2023-06-22 | Samsung Bioepis Co., Ltd. | Human genome-derived polynucleotide and method for producing polypeptide of interest using same |
| EP4516902A1 (en) | 2022-04-26 | 2025-03-05 | Daiichi Sankyo Company, Limited | Promoter of eno1 gene |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258294A (en) * | 1988-02-12 | 1993-11-02 | Commonwealth Scientific And Industrial Research Organisation | Bidirectional pox virus promoter element |
| US20070161003A1 (en) * | 2003-09-29 | 2007-07-12 | Morris David W | Novel therapeutic targets in cancer |
| EP2105742A1 (en) * | 2008-03-26 | 2009-09-30 | Sanofi-Aventis | Use of cathepsin C |
| JP5344682B2 (ja) * | 2008-12-26 | 2013-11-20 | グローブライド株式会社 | 釣糸ガイド、及び釣糸ガイドの製造方法 |
| ES2701091T3 (es) * | 2010-07-07 | 2019-02-20 | Daiichi Sankyo Co Ltd | Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno |
| CN104066839B (zh) * | 2011-11-28 | 2018-02-16 | 第一三共株式会社 | 衍生自人基因的启动子 |
-
2011
- 2011-07-06 ES ES15188915T patent/ES2701091T3/es active Active
- 2011-07-06 CN CN201610282337.5A patent/CN105950621B/zh active Active
- 2011-07-06 TW TW100123779A patent/TWI507523B/zh not_active IP Right Cessation
- 2011-07-06 RU RU2013104989/10A patent/RU2013104989A/ru not_active Application Discontinuation
- 2011-07-06 EP EP13186031.4A patent/EP2684961B1/en active Active
- 2011-07-06 JP JP2012555988A patent/JP5859988B2/ja active Active
- 2011-07-06 KR KR1020187005003A patent/KR101856927B1/ko active Active
- 2011-07-06 SG SG10201505354PA patent/SG10201505354PA/en unknown
- 2011-07-06 TW TW104134850A patent/TW201604280A/zh unknown
- 2011-07-06 EP EP15188915.1A patent/EP3026117B1/en active Active
- 2011-07-06 ES ES11743651.9T patent/ES2564227T3/es active Active
- 2011-07-06 CN CN2011800430998A patent/CN103080321A/zh active Pending
- 2011-07-06 BR BR112012033780A patent/BR112012033780A2/pt not_active IP Right Cessation
- 2011-07-06 WO PCT/JP2011/065916 patent/WO2012005378A2/en not_active Ceased
- 2011-07-06 CA CA2804381A patent/CA2804381C/en not_active Expired - Fee Related
- 2011-07-06 AU AU2011274864A patent/AU2011274864B2/en active Active
- 2011-07-06 CN CN201410141682.8A patent/CN103865931B/zh active Active
- 2011-07-06 SG SG10201705118RA patent/SG10201705118RA/en unknown
- 2011-07-06 KR KR1020137000305A patent/KR101833570B1/ko active Active
- 2011-07-06 SG SG2014009187A patent/SG2014009187A/en unknown
- 2011-07-06 ES ES13186031.4T patent/ES2565428T3/es active Active
- 2011-07-06 EP EP11743651.9A patent/EP2591113B1/en active Active
- 2011-07-06 CA CA2916937A patent/CA2916937A1/en not_active Abandoned
- 2011-07-06 KR KR1020187005004A patent/KR101920187B1/ko active Active
- 2011-07-06 SG SG2012094330A patent/SG186788A1/en unknown
-
2012
- 2012-12-27 US US13/728,809 patent/US9371543B2/en active Active
-
2015
- 2015-12-17 JP JP2015245827A patent/JP6039048B2/ja active Active
-
2016
- 2016-01-25 IL IL243763A patent/IL243763A0/en unknown
- 2016-05-23 US US15/162,294 patent/US10407694B2/en active Active
- 2016-06-02 AU AU2016203681A patent/AU2016203681B2/en active Active
-
2018
- 2018-01-30 AU AU2018200686A patent/AU2018200686B2/en active Active
-
2019
- 2019-07-26 US US16/523,547 patent/US11060108B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011062217A5 (enExample) | ||
| JP2012503478A5 (enExample) | ||
| JP2013531967A5 (enExample) | ||
| EA201390444A1 (ru) | Производство бутанола из монооксида углерода рекомбинантным микроорганизмом | |
| EA201300054A1 (ru) | Полипептид, обладающий активностью бета-глюкозидазы, и его применение | |
| JP2013530689A5 (enExample) | ||
| NZ600376A (en) | Elite event ee-gm3 and methods and kits for identifying such event in biological samples | |
| JP2012136542A5 (enExample) | ||
| JP2012115275A5 (enExample) | ||
| EA201201126A1 (ru) | Полипептид, обладающий активностью целлобиогидролазы, и его применение | |
| JP2012095652A5 (enExample) | ||
| MX2021000211A (es) | Metodos y productos para transfeccion de celulas. | |
| JP2013048638A5 (enExample) | ||
| EA201692359A1 (ru) | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса | |
| JP2011155981A5 (enExample) | ||
| JP2012223202A5 (enExample) | ||
| JP2011177189A5 (enExample) | ||
| WO2013049121A3 (en) | Recombinant phage and methods | |
| MX342664B (es) | Celulasas de familia 5 modificada y usos de las mismas. | |
| EA201170715A1 (ru) | Вектор, содержащий множественные гомологичные нуклеотидные последовательности | |
| JP2014520527A5 (enExample) | ||
| JP2016500260A5 (enExample) | ||
| RU2011142793A (ru) | Полученная из микроорганизма протеаза усовершенствованного типа, обеспечивающая свертывание молока | |
| MX365095B (es) | Métodos y composiciones para incrementar la producción de ácido siálico y tratar condiciones de enfermedades relacionadas siálicas. | |
| JP2013531491A5 (enExample) |